Chemcon Speciality Chemicals Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹65 Cr +21.9% YoYSee revenue, profit and what management said. You are viewing Q3 FY24.
CS

Chemcon Speciality Chemicals Ltd

Q3 FY24Chemicals & Petrochemicals

Chemcon Speciality Chemicals Q3 FY24 earnings call: Revenue & Margins

Q3 FY24 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹53Cr
−29.5% QoQ
Net profit
₹4Cr
−25.3% QoQ
Margin
11.97%
+0.9 pp QoQ

Based on Chemcon Speciality Chemicals Ltd's Q3 FY24 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹228
Market cap₹793 Cr
P/E28.1

The short version

Q3 FY24 Revenue from Operations: Rs. 53.0 Cr, down 30.7% YoY from Rs. 76.5 Cr in Q3 FY23 (Page 8). Q3 FY24 EBITDA: Rs. 6.3 Cr, down 53.0% YoY from Rs. 13.5 Cr in Q3 FY23.

From Chemcon Speciality Chemicals Ltd's Q3 FY24 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q3 FY24 Revenue from Operations: Rs. 53.0 Cr, down 30.7% YoY from Rs. 76.5 Cr in Q3 FY23 (Page 8)
  • Q3 FY24 EBITDA: Rs. 6.3 Cr, down 53.0% YoY (Page 8)
  • Q3 FY24 PAT: Rs. 4.4 Cr, down 60.9% YoY (Page 8)
  • Sales Volume Q3 FY24: 3,377 MT, down from 2,978 MT in Q3 FY23 (Page 6) — This shows a volume increase rather than decline
  • Volume growth of 13% YoY mainly driven by Inorganic Chemicals stated in Q3 FY24 Performance Highlights (Page 5)

2 more points from Chemcon Speciality Chemicals Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Chemcon Speciality Chemicals Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Capacity Expansion:
  • Addition of manufacturing capacity:
  • P-10 unit: To be commissioned by end of FY24; will manufacture organic chemicals.
  • P-11 unit: Expected commissioning by FY25; will manufacture organic chemicals.
  • Status:
  • P-10 and P-11 are proposed expansion plants, with P-10 expected by Q4 FY24 and P-11 by FY25.
  • Expansion plans aim to add organic chemical capacity (HMDS, CMIC, Bromobenzene).
  • Strategy:
  • Diversifying product portfolio and customer base.
  • Focus on import substitution and improving cost efficiencies through process re-engineering.

2 more points from Chemcon Speciality Chemicals Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Chemcon Speciality Chemicals Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Chemcon Speciality Chemicals Ltd said on order book & pipeline — free account, 30 seconds.

Chemcon Speciality Chemicals Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Chemcon Speciality Chemicals Ltd Q3 FY24 results — key figures

Chemcon Speciality Chemicals Ltd Q3 FY24 reported results vs year-ago quarter, ₹ crore
₹ CrQ3 FY24Q2 FY24QoQ
Revenue5375-29.5%
Operating profit (EBITDA)68-23.9%
Operating margin11.97%11.08%+0.9 pp
Profit before tax68-24.6%
Net profit (PAT)46-25.3%
EPS (₹)1.211.62-25.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹65 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Himadri Special (Q3 FY24)

    1,052.51 Cr, up 1.46% YoY from Rs. Key concall takeaways from Himadri Speciality Chemical Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.

  • Gujarat Alkalies (Q3 FY24)

    3,702.77 crores, down from Rs. Key concall takeaways from Gujarat Alkalies & Chemicals Ltd's Q3 FY24 earnings call — and how it ranks against sector peers.

  • Balaji Amines (Q3 FY24)

    Q3FY24 consolidated revenue from operations: ₹392 crore, down 33% YoY from ₹588 crore in Q3FY23 (Page 5, 7). Key concall takeaways from Balaji Amines Ltd's Q3…

  • Vidhi Specialty (Q3 FY24)

    Year-on-Year (Y-o-Y) change: -27.1% (Q3 FY24 vs Q3 FY23) . Key concall takeaways from Vidhi Specialty Food Ingredients Ltd's Q3 FY24 earnings call — and how it…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Chemcon Speciality Chemicals Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Chemcon Speciality Chemicals Ltd Q3 FY24 results?

Q3 FY24 Revenue from Operations: Rs. 53.0 Cr, down 30.7% YoY from Rs. 76.5 Cr in Q3 FY23 (Page 8). Q3 FY24 EBITDA: Rs. 6.3 Cr, down 53.0% YoY from Rs. 13.5 Cr in Q3 FY23.

What is Chemcon Speciality Chemicals Ltd share price analysis?

Chemcon Speciality Chemicals Ltd currently shows a neutral. The stock trades at a P/E of 28.1 with a market cap of ₹793 Cr. Investors should review the full earnings analysis for detailed insights.

Is Chemcon Speciality Chemicals Ltd planning capital expenditure?

Capacity Expansion: - Addition of manufacturing capacity: - P-10 unit: To be commissioned by end of FY24; will manufacture organic chemicals.

Keep Chemcon Speciality Chemicals Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.